WUTIF Capital

Founded in 2003, WUTIF Capital is an angel investment group based in Vancouver, Canada. It co-invests with angel investors in early-stage technology ventures across various sectors such as communications, information technology, health and life sciences technologies, physical sciences, energy, and fuel cells.

Michael Volker

President

Past deals in Vancouver

A&K Robotics

Seed Round in 2023
A&K Robotics Inc. is a Canadian company based in Vancouver, founded in 2015, that specializes in designing and building advanced robotic systems. The company focuses on developing intelligent navigation systems that enable robots to work collaboratively with humans. A&K Robotics also creates electric micro-mobility platforms and self-driving robotic pods, which aim to enhance mobility in large facilities such as airports, malls, and museums, as well as in crowded urban environments. By pushing the boundaries of robotics technology, A&K Robotics seeks to improve quality of life and promote environmental sustainability through innovative real-life applications.

Lucent BioSciences

Seed Round in 2021
Lucent Biosciences specializes in the development of innovative biofertilizers aimed at enhancing agricultural sustainability. The company offers a unique class of micronutrient fertilizers that promote higher crop yields and nutrient levels while being environmentally friendly. Their products are designed to improve soil health and sequester carbon, contributing to climate-positive farming practices. By utilizing sustainable bioactive crop nutrition, Lucent Biosciences enables farmers to cultivate nutrient-dense crops without polluting groundwater, thereby supporting regenerative agriculture and reducing overall costs per hectare.

Arbutus Medical

Seed Round in 2020
Founded in 2014, Arbutus Medical develops and manufactures surgical power tools aimed at reducing healthcare costs. Its flagship product is a radically affordable orthopedic power tool system used in trauma centers, veterinary hospitals, military deployments, and hospitals worldwide.

A&K Robotics

Pre Seed Round in 2020
A&K Robotics Inc. is a Canadian company based in Vancouver, founded in 2015, that specializes in designing and building advanced robotic systems. The company focuses on developing intelligent navigation systems that enable robots to work collaboratively with humans. A&K Robotics also creates electric micro-mobility platforms and self-driving robotic pods, which aim to enhance mobility in large facilities such as airports, malls, and museums, as well as in crowded urban environments. By pushing the boundaries of robotics technology, A&K Robotics seeks to improve quality of life and promote environmental sustainability through innovative real-life applications.

Alpha9 Theranostics

Seed Round in 2020
Alpha9 Theranostics is a biopharma company that focuses on radiotherapeutics for the treatment of solid and hematologic malignancies. The company is creating a strong pipeline of radiopharmaceuticals to target solid and hematologic malignancies. Its systematic approach to radiotherapeutic design is fueled by a toolbox of technologies and chemistries, which offers broad potential for expansion into a multitude of oncology targets. Alpha9 Theranostics was founded in 2019 and is headquartered in Vancouver, Canada.

Lucent BioSciences

Seed Round in 2020
Lucent Biosciences specializes in the development of innovative biofertilizers aimed at enhancing agricultural sustainability. The company offers a unique class of micronutrient fertilizers that promote higher crop yields and nutrient levels while being environmentally friendly. Their products are designed to improve soil health and sequester carbon, contributing to climate-positive farming practices. By utilizing sustainable bioactive crop nutrition, Lucent Biosciences enables farmers to cultivate nutrient-dense crops without polluting groundwater, thereby supporting regenerative agriculture and reducing overall costs per hectare.

Starling Minds

Seed Round in 2019
Founded in 2013, Starling Minds offers digital mental health solutions, including cognitive behavioral therapy programs. It caters to businesses, healthcare providers, and educational institutions, aiming to enhance emotional resilience, manage stress, anxiety, and depression, thereby improving workplace productivity.

Mesentech

Seed Round in 2019
Mesentech Inc. is a regenerative medicine company based in Vancouver, Canada, focused on developing innovative therapies for bone-related diseases. Established in 2013, the company specializes in a prodrug platform that delivers therapeutics selectively to bone, addressing challenges associated with conventional drug delivery methods. Mesentech's lead product, MES1007, is a bone-targeted prodrug of a prostaglandin mimetic that aims to reverse bone loss associated with conditions such as osteoporosis and Duchenne muscular dystrophy. The company's proprietary technology enhances the delivery of small-molecule and biological drugs to the bone's surface and interior, allowing for more effective treatment while minimizing side effects. This approach is particularly significant given the inherent difficulty in accessing bone tissue due to its hard surface and low porosity. Mesentech's focus on selective drug delivery not only aims to improve treatment efficacy but also hopes to accelerate bone healing and address complications associated with low bone density disorders.

Keycafe

Seed Round in 2019
Keycafe Inc. offers an online platform that enables the remote management of access to homes and rental properties. Established in 2012 and headquartered in Vancouver, Canada, the company provides a combination of software as a service (SaaS) and Internet of Things (IoT) solutions for efficient key exchange and property access management. It caters to both consumers and enterprises, facilitating secure and convenient access for homeowners and rental property managers.

ThisFish

Seed Round in 2018
ThisFish enhances profitability and sustainability within the global seafood industry by digitizing operations, ensuring traceability, and driving innovation. Its software reduces costs, bolsters process control, and facilitates compliance across international supply chains.

Starling Minds

Seed Round in 2018
Founded in 2013, Starling Minds offers digital mental health solutions, including cognitive behavioral therapy programs. It caters to businesses, healthcare providers, and educational institutions, aiming to enhance emotional resilience, manage stress, anxiety, and depression, thereby improving workplace productivity.

Wantering

Seed Round in 2012
Wantering operates an online fashion discovery platform designed to help users find and purchase clothing from various sources. The platform aggregates content from fashion blogs and social networks, presenting users with a curated selection of interesting fashion products available across boutiques, flash sales sites, and major retailers. Based in Vancouver, Canada, Wantering streamlines the shopping experience by consolidating multiple retail options into one accessible location.

LightIntegra Technology

Seed Round in 2009
LightIntegra Technology Inc., established in 2009 and headquartered in Vancouver, Canada, is a privately-funded medical diagnostics company specializing in innovative in-vitro diagnostic tests. The company's flagship product, ThromboLUX, is designed to provide healthcare professionals with qualitative and quantitative information about microparticle content in platelet samples. LightIntegra offers the ThromboLUX test kit, control kit, and ThromboSight, a software tool for analyzing test results. Founded by Dr. Elisabeth Maurer, a research scientist from Canadian Blood Services R&D labs, the company aims to minimize platelet refractoriness through its products.

Bionic Power

Seed Round in 2007
Bionic Power is a privately-held technology company based in Vancouver, British Columbia, specializing in wearable technology aimed at enhancing personal mobility. The company focuses on developing its PowerWalk® Kinetic Energy Harvester, primarily for the U.S. military, which allows users to charge batteries through kinetic energy. In addition to this, Bionic Power designs lower-body smart orthoses that improve the quality of life for individuals with mobility challenges. These orthoses enhance knee motion during walking, rebuild weakened muscles, and overall improve walking efficiency, thereby reducing fatigue and increasing mobility for users.

MailChannels

Seed Round in 2007
MailChannels Corporation specializes in email filtering and delivery solutions aimed at addressing IP blacklisting and spam challenges. Founded in 2004 and headquartered in Vancouver, Canada, the company offers products such as MailChannels Cloud, an email relay service that enhances email reputation and delivery reliability by identifying spammers within a network, and MailChannels Dedicated, a robust software solution designed to block spam from reaching the Internet. Catering primarily to shared hosting, dedicated hosting, VPS hosting, cloud hosting, and Internet service providers, MailChannels helps clients like Enom, Arvixe, SendGrid, SherWeb, and Hostwinds improve customer satisfaction and secure their outbound email traffic.

Aprio

Seed Round in 2005
Aprio is a governance technology company that provides a board portal and board management platform designed to simplify and make governance affordable for organizations of all sizes. The software supports board meetings, prepares agendas, uploads and distributes packages, tracks board activity, and securely manages documents so directors stay up to date and information remains secure. It enables remote collaboration, streamlined decision-making, and transparent communication, serving financial institutions, crown corporations, non-profits, and public companies across North America.

Zymeworks

Seed Round in 2005
Zymeworks is a biotechnology company focused on optimizing protein-based therapeutics, particularly for cancer treatment. It uses proprietary computational methods to engineer differentiated product candidates, with its lead asset zanidatamab in multiple clinical trials targeting HER2-expressing solid tumors.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.